Cargando…

Predicting the Lung Adenocarcinoma and Its Biomarkers by Integrating Gene Expression and DNA Methylation Data

The early symptoms of lung adenocarcinoma patients are inapparent, and the clinical diagnosis of lung adenocarcinoma is primarily through X-ray examination and pathological section examination, whereas the discovery of biomarkers points out another direction for the diagnosis of lung adenocarcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Wang-Ren, Qi, Bei-Bei, Lin, Wei-Zhong, Zhang, Shou-Hua, Yu, Wang-Ke, Huang, Shun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280023/ https://www.ncbi.nlm.nih.gov/pubmed/35846148 http://dx.doi.org/10.3389/fgene.2022.926927

Ejemplares similares

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers
por: Ren, Jin, et al.
Publicado: (2021)

An integrative analysis of DNA methylation and gene expression to predict lung adenocarcinoma prognosis
por: Xu, Liexi, et al.
Publicado: (2022)

Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma
por: Cai, Wenhan, et al.
Publicado: (2022)

Integrative analysis of DNA methylomes reveals novel cell-free biomarkers in lung adenocarcinoma
por: Chen, Yifan, et al.
Publicado: (2023)

Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019)

m(6)A RNA Methylation Regulators Act as Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Wang, Hongbo, et al.
Publicado: (2021)

A Nomogram Integrating Ferroptosis- and Immune-Related Biomarkers for Prediction of Overall Survival in Lung Adenocarcinoma
por: Chai, Mengyu, et al.
Publicado: (2021)

Integrating Genetic and Transcriptomic Data to Reveal Pathogenesis and Prognostic Markers of Pancreatic Adenocarcinoma
por: Bai, Kaisong, et al.
Publicado: (2021)

Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease
por: Sato, Takashi, et al.
Publicado: (2014)

DNA Methylation Cancer Biomarkers: Translation to the Clinic
por: Locke, Warwick J., et al.
Publicado: (2019)

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

Identification of Potential Biomarkers for CAD Using Integrated Expression and Methylation Data
por: Zhang, Xiaokang, et al.
Publicado: (2020)

Identification of DNA methylation biomarkers from Infinium arrays
por: Wessely, Frank, et al.
Publicado: (2012)

DNA Methylation Biomarkers in Aging and Age-Related Diseases
por: Salameh, Yasmeen, et al.
Publicado: (2020)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection
por: Zhao, Guodong, et al.
Publicado: (2020)

Integrative Analysis of Membrane Proteome and MicroRNA Reveals Novel Lung Cancer Metastasis Biomarkers
por: Kong, Yan, et al.
Publicado: (2020)

DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer
por: Zeng, Yunqing, et al.
Publicado: (2022)

Identification of Potential Long Non-coding RNA Expression Quantitative Trait Methylations in Lung Adenocarcinoma and Lung Squamous Carcinoma
por: Wu, Xiaohong, et al.
Publicado: (2020)

One Ferroptosis-Related Gene-Pair Signature Serves as an Original Prognostic Biomarker in Lung Adenocarcinoma
por: Li, Lei, et al.
Publicado: (2022)

DNA methylation results depend on DNA integrity—role of post mortem interval
por: Rhein, Mathias, et al.
Publicado: (2015)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates
por: Wei, Qin, et al.
Publicado: (2022)

Comprehensive bioinformatics analysis reveals biomarkers of DNA methylation-related genes in varicose veins
por: Li, Shengyu, et al.
Publicado: (2022)

Comprehensive circular RNA expression profile of lung adenocarcinoma with bone metastasis: Identification of potential biomarkers
por: Cai, Ying, et al.
Publicado: (2022)

Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis
por: Lyu, Shi-Yi, et al.
Publicado: (2023)

Positive regulators of T cell proliferation as biomarkers for predicting prognosis and characterizing the immune landscape in lung adenocarcinoma
por: Li, Yang, et al.
Publicado: (2022)

Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation
por: Feng, Yao, et al.
Publicado: (2023)

Identification of Potential Biomarkers for Psoriasis by DNA Methylation and Gene Expression Datasets
por: Liu, Yong, et al.
Publicado: (2021)

The Identification of Critical m(6)A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma
por: Xu, Jiaju, et al.
Publicado: (2020)

Elastic Net Models Based on DNA Copy Number Variations Predicts Clinical Features, Expression Signatures, and Mutations in Lung Adenocarcinoma
por: Xiang, Yi, et al.
Publicado: (2021)

m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
por: Li, Fangwei, et al.
Publicado: (2020)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Zeng, Zhen, et al.
Publicado: (2022)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

Corrigendum: Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis
por: Lyu, Shi-Yi, et al.
Publicado: (2023)

Mitochondrial Homeostasis–Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2022)

DNASE1L3 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma Based on Data Mining
por: Chen, Jianlin, et al.
Publicado: (2021)

Identification and Validation of Two Lung Adenocarcinoma-Development Characteristic Gene Sets for Diagnosing Lung Adenocarcinoma and Predicting Prognosis
por: Liu, Cheng, et al.
Publicado: (2020)

Integrated Analysis Reveals the Potential Significance of HDAC Family Genes in Lung Adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

Single-cell RNA sequencing analysis to explore immune cell heterogeneity and novel biomarkers for the prognosis of lung adenocarcinoma
por: Xu, Yong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_im356q3pahuh83hadrfecv5fb6